© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb)
Section of Cardiovascular Sciences, Baylor College of Medicine and the De Bakey Heart Center, The Methodist Hospital, Houston TX, USA
* Corresponding author. Tel.: +1-713-798-4188; fax: +1-713-796-0015 ngf{at}bcm.tmc.edu
Objective: The purpose of this study is to examine the cellular content of healing myocardial infarcts and study the phenotypic characteristics of fibroblasts during scar formation utilizing a canine model of coronary occlusion and reperfusion. Methods: Ischemia/Reperfusion experiments were performed in dogs undergoing 1 h of coronary occlusion followed by reperfusion intervals ranging from 5 h to 28 days. Fibrotic and control areas were studied using immunohistochemistry. Results: The healing ischemic and reperfused myocardium demonstrated significant proliferative activity peaking after 3 to 7 days of reperfusion, predominantly in myofibroblasts. The numbers of proliferating cells decreased during the maturation phase of the scar (PCNA index: 13.7±2.25% at 5 days vs. 4.8±1.1% at 28 days; P<0.05, n = 5). During the proliferative phase of healing (3–7 days) 
-smooth muscle actin (-SMAc) expression was markedly increased in the fibrotic areas. -SMAc predominantly localized in myofibroblasts which were vimentin positive, smooth muscle myosin, calponin and desmin negative. We examined expression of smooth muscle myosin heavy chain isoforms in myofibroblasts infiltrating the healing areas and found a marked induction of the embryonal isoform of myosin heavy chain (SMemb) in -SMAc positive spindle shaped cells in the border of the scar. Myofibroblasts did not express SM2, a marker for mature smooth muscle cells. In contrast myocardial arterioles were positive for SM2, but did not express SMemb. Conclusions: Healing myocardial infarcts undergo rapid changes in their content of myofibroblasts. During the proliferative phase fibroblasts undergo phenotypic changes leading to expression of contractile proteins such as -SMAc, and production of SMemb, a marker for dedifferentiated smooth muscle cells. Expression of embryonic isoforms indicates dedifferentiation and allows the myofibroblast pool to serve as a versatile cell population, assuming different phenotypes depending on the physiological needs.
KEYWORDS Fibrosis; Histo(patho)logy; Infarction; Reperfusion; Smooth muscle
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Jones, C. Beck, J. R. Barbour, J. A. Zavadzkas, R. Mukherjee, F. G. Spinale, and J. S. Ikonomidis Alterations in Aortic Cellular Constituents during Thoracic Aortic Aneurysm Development: Myofibroblast-Mediated Vascular Remodeling Am. J. Pathol., October 1, 2009; 175(4): 1746 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Roy, S. Khanna, T. Rink, J. Radtke, W. T. Williams, S. Biswas, R. Schnitt, A. R. Strauch, and C. K. Sen p21waf1/cip1/sdi1 as a Central Regulator of Inducible Smooth Muscle Actin Expression and Differentiation of Cardiac Fibroblasts to Myofibroblasts Mol. Biol. Cell, December 1, 2007; 18(12): 4837 - 4846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Grauss, E. M. Winter, J. van Tuyn, D. A. Pijnappels, R. V. Steijn, B. Hogers, R. J. van der Geest, A. A. F. de Vries, P. Steendijk, A. van der Laarse, et al. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2438 - H2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Drobic, R. H. Cunnington, K. M. Bedosky, J. E. Raizman, V. V. Elimban, S. G. Rattan, and I. M. C. Dixon Differential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contraction Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1053 - H1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Frangogiannis, G. Ren, O. Dewald, P. Zymek, S. Haudek, A. Koerting, K. Winkelmann, L. H. Michael, J. Lawler, and M. L. Entman Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts Circulation, June 7, 2005; 111(22): 2935 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Freed, R. H. Cunnington, A. L. Dangerfield, J. S. Sutton, and I. M.C. Dixon Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart Cardiovasc Res, March 1, 2005; 65(4): 782 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yoshida and G. K. Owens Molecular Determinants of Vascular Smooth Muscle Cell Diversity Circ. Res., February 18, 2005; 96(3): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dobaczewski, S. Akrivakis, K. Nasser, L. H. Michael, M. L. Entman, and N. G. Frangogiannis Vascular Mural Cells in Healing Canine Myocardial Infarcts J. Histochem. Cytochem., August 1, 2004; 52(8): 1019 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Dewald, G. Ren, G. D. Duerr, M. Zoerlein, C. Klemm, C. Gersch, S. Tincey, L. H. Michael, M. L. Entman, and N. G. Frangogiannis Of Mice and Dogs: Species-Specific Differences in the Inflammatory Response Following Myocardial Infarction Am. J. Pathol., February 1, 2004; 164(2): 665 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Roy, S. Khanna, W. A. Wallace, J. Lappalainen, C. Rink, A. J. Cardounel, J. L. Zweier, and C. K. Sen Characterization of Perceived Hyperoxia in Isolated Primary Cardiac Fibroblasts and in the Reoxygenated Heart J. Biol. Chem., November 21, 2003; 278(47): 47129 - 47135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matsumura, S. Miyagawa-Tomita, T. Shin'oka, Y. Ikada, and H. Kurosawa First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo Circulation, October 7, 2003; 108(14): 1729 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Frangogiannis, L. H. Mendoza, G. Ren, S. Akrivakis, P. L. Jackson, L. H. Michael, C. W. Smith, and M. L. Entman MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H483 - H492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Manabe, T. Shindo, and R. Nagai Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy Circ. Res., December 13, 2002; 91(12): 1103 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Badid, A. Desmouliere, D. Babici, A. Hadj-Aissa, B. McGregor, N. Lefrancois, J. L. Touraine, and M. Laville Interstitial expression of {alpha}-SMA: an early marker of chronic renal allograft dysfunction Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1993 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Cogan, S. V. Subramanian, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch Vascular Smooth Muscle alpha -Actin Gene Transcription during Myofibroblast Differentiation Requires Sp1/3 Protein Binding Proximal to the MCAT Enhancer J. Biol. Chem., September 20, 2002; 277(39): 36433 - 36442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Frangogiannis, S. Shimoni, S. Chang, G. Ren, O. Dewald, C. Gersch, K. Shan, C. Aggeli, M. Reardon, G. V. Letsou, et al. Active interstitial remodeling: an important process in the hibernating human myocardium J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1468 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Frangogiannis, S. Shimoni, S. M. Chang, G. Ren, K. Shan, C. Aggeli, M. J. Reardon, G. V. Letsou, R. Espada, M. Ramchandani, et al. Evidence for an Active Inflammatory Process in the Hibernating Human Myocardium Am. J. Pathol., April 1, 2002; 160(4): 1425 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ren, L. H. Michael, M. L. Entman, and N. G. Frangogiannis Morphological Characteristics of the Microvasculature in Healing Myocardial Infarcts J. Histochem. Cytochem., January 1, 2002; 50(1): 71 - 80. [Abstract] [Full Text]
|
|